edificio sede de HP SCDS en León

HP and mAbxience apply AI to optimize biosimilars production

HP SCDS alongside mAbxience have developed an artificial intelligence (AI)-based solution that optimizes the production of monoclonal antibodies and biosimilars, which are essential treatments for thousands of patients worldwide.
Tagged under: , ,